“…The genetic bases for different breathing patterns in different strains of mice at rest and in response to hypoxic and hypercapnic challenges have received extensive study ( Tankersley et al, 1994 ; Tankersley et al, 1998 ; Tankersley et al, 2000a ; Tankersley et al, 2000b ; Tankersley et al, 2000c ; Han and Strohl, 2000 ; Tankersley, 2000 ; Tankersley, 2001 ; Tankersley, 2003 ; Tankersley and Broman, 2004 ; Balbir et al, 2006 ; Gillombardo et al, 2012 ; Strohl et al, 2012 ) as have the genetic bases for the differences involve many neurochemical processes ( Tankersley et al, 2002a ; Tankersley et al, 2002b ; Tankersley et al, 2002c ; Price et al, 2003 ; Groeben et al, 2005 ; Yamauchi et al, 2008a ; Yamauchi et al, 2008b ; Moore et al, 2012 ; Moore et al, 2014 ), and structural features of respiratory structures, such as the carotid body ( Yamaguchi et al, 2003 ; Yamaguchi et al, 2006 ; Chai et al, 2011 ). The possibility that HDAC6 is a key player in the genetic factors that regulate ventilatory control processes per se , and those that respond to a hypoxic gas challenge, opens up intriguing avenues of research including those testing whether administration of selective HDAC6 inhibitors, such as CAY10603, Tubacin and Nexturastat ( Lu et al, 2017 ; Govers et al, 2019 ; Ma et al, 2019 ; Sanaei and Kavoosi, 2019 ; Sun et al, 2019 ), augment/stabilize ventilatory responses to hypoxic and/or hypercapnic challenges in mouse models, such as C57BL/6 mice ( Yamauchi et al, 2007 ; Yamauchi et al, 2008a ; Yamauchi et al, 2008b ; Yamauchi et al, 2008c ; Yamauchi et al, 2010 ).…”